3-(2-fluorophenyl)-2-((2-methyl-2H-1,2,4-triazol-3-yl)methoxy)-7-(pyridin-3-yl)pyrazolo[1,5-d][1,2,4]triazine

ID: ALA210400

PubChem CID: 18406910

Max Phase: Preclinical

Molecular Formula: C20H15FN8O

Molecular Weight: 402.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ncnc1COc1nn2c(-c3cccnc3)nncc2c1-c1ccccc1F

Standard InChI:  InChI=1S/C20H15FN8O/c1-28-17(23-12-25-28)11-30-20-18(14-6-2-3-7-15(14)21)16-10-24-26-19(29(16)27-20)13-5-4-8-22-9-13/h2-10,12H,11H2,1H3

Standard InChI Key:  LYXHWNNDUVMWRX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
    2.3445   -9.3018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5279   -9.4458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4108  -10.2624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1513  -10.6262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7261  -10.0343    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5424  -10.1537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0511   -5.0280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4821   -5.8552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4789   -5.0241    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7607   -4.6152    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7628   -6.2685    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0483   -5.8525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4318   -6.4033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7652   -7.1599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5877   -7.0765    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3499   -7.8728    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7158   -5.9938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7187   -5.1716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0037   -4.7614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2895   -5.1762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2948   -6.0055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0104   -6.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1970   -6.2670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1956   -7.0918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9096   -7.5037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6247   -7.0904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6213   -6.2611    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9066   -5.8531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7597   -8.5889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0180   -7.2369    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
 14 15  2  0
 15 11  1  0
  2  3  1  0
 14 16  1  0
 11  8  1  0
 13 17  1  0
  3  4  2  0
 17 18  2  0
  8  9  2  0
 18 19  1  0
  4  5  1  0
 19 20  2  0
  9 10  1  0
 20 21  1  0
 10  7  2  0
 21 22  2  0
 22 17  1  0
 11 12  1  0
  8 23  1  0
  5  1  1  0
 23 24  2  0
 24 25  1  0
  5  6  1  0
 25 26  2  0
  1  2  2  0
 26 27  1  0
  7 12  1  0
 27 28  2  0
 28 23  1  0
 12 13  2  0
 16 29  1  0
 29  1  1  0
 13 14  1  0
 22 30  1  0
M  END

Associated Targets(Human)

GABRG2 Tclin GABA-A receptor; alpha-3/beta-3/gamma-2 (1250 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA-A receptor; alpha-1/beta-3/gamma-2 (1565 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 402.39Molecular Weight (Monoisotopic): 402.1353AlogP: 2.70#Rotatable Bonds: 5
Polar Surface Area: 95.91Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.81CX LogP: 1.90CX LogD: 1.90
Aromatic Rings: 5Heavy Atoms: 30QED Weighted: 0.45Np Likeness Score: -1.81

References

1. Carling RW, Russell MG, Moore KW, Mitchinson A, Guiblin A, Smith A, Wafford KA, Marshall G, Atack JR, Street LJ..  (2006)  2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonists.,  16  (13): [PMID:16621541] [10.1016/j.bmcl.2006.03.081]

Source